Products/Active Agents Index
This index includes nomenclature terms from
Biopharmaceuticals in the U.S. and European Markets for products and their active
ingredients.
See the Chemical Index for all other ingredients, chemicals used in
processing, contaminants, etc.
See the Biological Index for bioprocessing terms.
This index includes a variety of types of nomenclature, including chemical, regulatory,
biological, and author-contrived descriptive terms (e.g., the unique short names used for products;
see the User's Guide).
This index does not include products/agents that are not the main subject of monographs (e.g., competing products and those in development discussed in monographs).
Use the online Products database full text field to retrieve these other products. This is an unedited list from the 7th edition, 1st draft (10/26/08), database, with more indexing and editing to be done.
- 10A1C6, Chinese ovary hamster (CHO) cells -- 148;
- 1454 Saccharomyces cerevisiae (yeast) cells -- 182;
- 2.131 Chinese hamster ovary (CHO) cell line -- 187;
- 20,752, Haemophilus influenzae type b strain -- 456.5;
- 2150-2-3, Saccharomyces cerevisiae (yeast) strain -- 174;
175;
178;
- 225 murine hybridoma cells -- 128;
- 225.28S murine hybridoma -- 309;
- 2B8 murine hybridoma cells -- 117;
- (3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide) [MTT] -- 652;
- 3T3 feeder cells, murine -- 653;
- 4-4FC102A5-3 Chinese hamster ovary cells -- 267;
- 4-hydroxydehydrogenase -- 241;
- 4D5 murine hybridoma cells -- 179;
- 4D5-8 5 murine hybridoma cells -- 179;
- 5'HS4 element -- 102;
- 5G1.1 murine monoclonal antibody -- 120;
- 7E11-C5.3 murine hybridoma cells -- 312;
- 89-12C2, rotavirus -- 530;
- A2 murine hybridoma cells -- 264;
- A375 cells -- 267;
- A4.6.1 hybridoma cells -- 275;
- AB103 -- 193;
- ABX-CHO2-P media -- 129;
- AcNPV p10 promotor -- 271;
- ACUSYST perfusion bioreactors -- 119;
312;
- Ad5 vector -- 232;
233;
- Adekanol LG-109 -- 415;
- adenine -- 651;
659;
- adenosine -- 148;
- adenosine diphosphate (ADP) ribosylation -- 217;
- adenovirus 2 late promoter -- 243;
- adenovirus serotype 5 (Ad5) vector -- 232;
233;
261.7;
- adenovirus vector -- 261.7;
- adw, hepatitis B virus subtype -- 174;
- African green monkey kidney (AFMK) cells -- 483.8;
- African green monkey kidney cells -- 437.5;
440;
445;
446.5;
490;
517;
520;
521;
530;
531;
532;
540;
- agar -- 406;
563;
- agarose -- 651;
659;
- Agkistrodon contortrix contortrix -- 153;
- Agkistrodon piscivorus venom -- 908;
- AIM media -- 242;
- air-lift fermenters -- 313;
- Albumin (Human) -- 491;
504;
- albumin-digoxin conjugate -- 913;
- albumin, bovine serum -- 115;
147;
152;
162;
245;
312;
651;
- aldehyde dehydrogenase -- 241;
- alkaline phosphatase secretory signal sequence -- 271;
- allantoic fluid -- 471;
472;
478;
479;
480;
504;
567;
932;
- alpha-2 plasmin inhibitor signal sequence -- 261;
- alpha-S1 casein milk-specific promoter, bovine -- 113;
- Alpine goats -- 102;
- amphotericin B -- 402;
403;
529;
532;
- ampicillin -- 220;
- ampicillin resistance marker gene -- 105;
- animal source materials (unspecified) -- 143;
- Anthrax Vaccine Adsorbed -- 744;
745;
746;
- antibody photoactivation -- 301;
- antifoam agent -- 230;
- Antigen Presenting Cells (APC) -- 242;
- apheresis (hemapheresis) -- 802;
- apoptosis -- 232;
233;
261.7;
713.5;
- AR58, Escherichia coli (E. coli) -- 230;
- ARG3 gene termination sequence -- 175;
- arylsulfatase -- 182;
- ascitic fluid -- 303;
304;
307;
- asparagine -- 105;
410;
- Aspergillus flavus -- 272;
- ATCC 10762 -- 123;
- ATCC 20670 -- 193;
- ATCC 20705 -- 175;
- ATCC 27325 -- 120;
- ATCC 39262 -- 230;
- ATCC 39626 -- 218;
- ATCC 39685 -- 166;
- ATCC 53281 -- 457;
- ATCC 68088 -- 267;
- ATCC CCL 10 -- 149;
- ATCC CCL 81 -- 517;
- ATCC CRL 10859 and 10860 -- 185;
- ATCC CRL 1573 -- 243;
- ATCC CRL 8001 -- 303;
- ATCC CRL 8287 -- 264;
- ATCC CRL1573 -- 261.7;
- ATCC HB 10494 -- 312;
- ATCC HB 11552 -- 147;
148;
719;
721;
722;
- ATCC HB-11625 -- 120;
- ATCC HB-8483 -- 701;
- ATCC HB10710 -- 275;
- ATCC HB11388 -- 117;
- ATCC HB8832 -- 240;
- ATCC no. CCL 61 -- 269;
- ATCC PTA 2104 -- 123.5;
- ATCC PTA-1883 -- 301;
- ATCC VR 2089, VR 2090, VR 2091, VR 2092, VR 2093 -- 463;
- ATCC VR-2272 -- 530;
- Autographa californica nuclear polyhedrosis virus (AcNPV) baculovirus polyhedron expression promoter -- 191.5;
- autologous blood
- autologous cells, human -- 649.5;
650;
650.3;
650.5;
654;
702;
742;
- B-lymphocytes -- 271;
417;
- B2.6.2, hybridoma cells -- 275;
- B43.13
- B72.3 hybridoma cells -- 313;
- baby hamster kidney (BHK) cells -- 145;
149;
151;
- Bacille Calmette Guerin (BCG) -- 407;
408;
409;
410;
411;
412;
- Bacillis anthracis Vollum strain (V770) -- 404;
- bacillus Calmette-Guerin (BCG) -- 649.5;
649.5;
- bacterial culture -- 103;
104;
110;
118;
158;
159;
160.1;
160.2;
160.3;
160.7;
160.8;
160.9;
165;
170;
171;
192;
192.3;
192.5;
194;
197;
198;
199;
201;
202;
204;
205;
206;
208;
209;
212;
213;
214;
216;
217;
218;
219;
220;
226;
229;
230;
231;
234;
235;
236;
250;
251;
252;
253;
254;
256;
258;
259;
261.5;
266;
268;
274;
404;
405;
406;
407;
408;
409;
410;
411;
412;
413;
414;
415;
418;
419;
420;
421;
422;
423;
424;
425;
426;
427;
428;
429;
430;
431;
432;
433;
434;
435;
436;
437;
437.5;
439;
440;
441;
442;
443;
444;
445;
446;
446.5;
447;
448;
449;
450;
451;
452;
453;
454;
455;
456;
456.5;
457;
458;
459;
460;
497;
498;
499;
500;
502;
502.5;
503;
505;
506;
507;
508;
509;
510;
511;
512;
513;
- bacterial culture -- 513.3;
513.5;
514;
515;
542;
543;
544;
545;
546;
547;
548;
549;
550;
551;
552;
553;
554;
555;
556;
557;
558;
559;
560;
561;
562;
563;
602;
604;
608;
609;
611;
624;
625;
700;
926;
927;
929;
938;
- bacteriophage T4 -- 260;
- baculovirus 61K signal peptide -- 191.5;
- baculovirus expression -- 185;
242;
271;
- baculovirus pPSC12 plasmid -- 191.5;
- BALB/c mice -- 264;
304;
312;
- Bcl-2 gene -- 945;
- Bean strain, Clostridium botulinum -- 604;
- beef extract -- 196;
- beef heart infusion -- 612;
- Benzonase -- 245;
- Benzonase -- 483.8;
539;
540;
- beta casein gene (CSN2), goat -- 102;
- beta-casein promoter -- 102;
- BG9015/BG9216, Chinese Hamster Ovary cells -- 210;
- BgII fragment of pNM1 -- 112;
- BHK-21 (C-13) -- 149;
- bioreactors, 10,000 Liter -- 245;
- bioreactors, 12,000 L -- 270;
- bioreactors, air-lift fermentors -- 313;
- bioreactors, CellCube parallel-plate -- 232;
- bioreactors, hollow-fiber -- 416;
- bioreactors, parallel-plate -- 539;
- bioreactors, perfusion -- 105;
119;
149;
150;
150.5;
163;
232;
264;
312;
409;
539;
540;
- bioreactors, spinner culture -- 105;
144;
245;
275;
- BK virus enhancer -- 243;
- black widow spiders -- 909;
- blood infusion media, ovine -- 406;
- blood chromatography, human -- 700;
- blood donations -- 702;
- Bluescript (Stratagene) plasmid -- 267;
- bone marrow -- 649;
- Bordet Gengou medium -- 447;
509;
- Bordetella pertussis -- 429;
430;
431;
432;
433;
434;
435;
436;
437;
437.5;
443;
444;
445;
446;
447;
448;
449;
450;
451;
452;
505;
506;
507;
508;
509;
510;
- Bordetella pertussis S1 subunit gene -- 236;
- Borellia burgdorferi -- 229;
- Borellia burgdorferi, sensu stricto ZS7 strain -- 230;
- Bothrops atrox -- 907;
- botulinum toxins -- 911;
912;
- bouillon (beef) -- 624;
- bovine (veal) infusion agar -- 563;
- bovine Achilles tendon -- 612;
- bovine brain infusion media -- 406;
- bovine collagen -- 656;
- bovine heart -- 406;
- bovine heart infusion media -- 406;
- bovine insulin -- 651;
659;
- bovine lipoproteins -- 245;
- bovine lymph -- 536;
537;
- bovine materials -- 264;
445;
531;
565;
602;
605;
614;
921;
941;
942;
- bovine pancreas -- 614;
631;
- bovine proteins -- 514;
- bovine rotavirus G6 strain WC-3 (WC-3) -- 531;
- bovine serum -- 145;
163;
304;
312;
491;
504;
517;
520;
521;
531;
532;
533;
540;
564;
653;
659;
794;
- bovine serum albumin -- 490;
- bovine serum albumin (BSA) -- 147;
152;
245;
312;
651;
659;
900;
- bovine testes -- 616;
617;
618;
- bovine tissue digest -- 562;
- bovine transferrin -- 162;
245;
312;
- bovine-human reassortant viruses -- 531;
- brains, bovine media -- 406;
- Branhamella catarrhalis -- 406;
- BrB, human rotavirus stain -- 531;
- butyric acid (butyrate) -- 168;
168.5;
- C-127 (C127) murine tumor cells -- 257;
- c-ErbB-1 -- 128;
- c168A, mammalian cell line -- 264;
- C7 (beta197), Corynebacterium diphtheriae -- 457;
- CA 125, ovarian tumor antigen -- 302;
- CA125
- cabbage looper Trichoplasia ni High Five cell line -- 185;
271;
- CAF3, mice, CAF3 pathogen-free males -- 303;
- calcitonin-glycine fusion protein -- 110;
- calcium chloride -- 651;
659;
- calves, postmortem lung lavage -- 942;
- canine kidney cells Madin-Darby (MDCK) -- 483;
- carbon dioxide -- 651;
- carcinoembryonic antigen (CEA) gene -- 111;
- Carica papaya -- 622;
- carrot cells -- 167.3;
- cartilage, femoral articular (human) -- 650;
650.3;
- casamino acids -- 220;
430;
457;
- casein -- 436;
562;
- casein gene (CSN2), beta, goat -- 102;
- casein hydrolysate -- 423;
547;
601;
- caterpillar
242;
271;
- cathepsin L inhibition -- 105;
- CC49 murine hybridoma cells -- 315;
- CD15 antigen -- 305;
- CD3 -- 131;
131.5;
- CDF1 mice -- 304;
- cell proliferation bioassay -- 258;
- CellCube parallel-plate bioreactors -- 232;
- CelliGen bioreactors -- 232;
- cells, human -- 261.7;
702;
797;
802;
803;
806;
- cells, human -- 118;
121;
141;
162;
232;
233;
242;
243;
261.7;
265;
267;
402;
403;
463;
464;
466;
489;
492;
493;
493.5;
494;
494.5;
495;
496;
518;
526;
527;
533;
534;
539;
540;
564;
565;
626;
627;
649;
650;
650.3;
650.5;
651;
652;
653;
654;
656;
794;
795;
- Challenge Virus Standard (CVS; rabies virus) -- 528;
- CHAT 10A-11 cell line -- 516;
- chicken (rooster) combs -- 926;
928;
930;
- chicken beta-globin insulator sequence -- 102;
- chicken embryo (egg) culture -- 191.1;
- chicken embryo (egg) culture -- 471;
472;
473;
474;
475;
476;
477;
478;
479;
480;
481.5;
482;
- chicken embryo (egg) culture -- 483.11;
- chicken embryo (egg) culture -- 483.2;
- chicken embryo (egg) culture -- 483.3;
- chicken embryo (egg) culture -- 483.4;
- chicken embryo (egg) culture -- 483.7;
487;
488;
491;
492;
493;
493.5;
494;
494.5;
495;
496;
504;
529;
534;
566;
567;
932;
- chicken embryo dermal cells -- 111;
- chicken embryo fibroblast (CEF) cells -- 541;
- chicken embryo fibroblast cell culture -- 541;
- chicken embryos (eggs) -- 190;
191;
485;
- chicken embryos (eggs) (mammalian.poultry.chicken) -- 191;
- chimpanzee kidney cells -- 516;
- Chinese hamster ovary (CHO) cells -- 105;
108;
109;
110;
114;
115;
116;
116.5;
117;
119;
122;
123;
123.5;
126;
129;
130;
131.5;
133;
134;
135;
136;
137;
139;
140;
143;
144;
146;
147;
150;
150.5;
152;
155;
156;
160;
163;
167;
172;
179;
186;
188;
189;
202;
210;
211;
222.4;
222.6;
227;
228;
244;
261;
262;
267;
270;
- Chinese hamster ovary (CHO) cells, 2.131 -- 187;
- Chinese hamster ovary (CHO) cells, CHO-K1 -- 269;
- Chinese hamster ovary (CHO) cells, CHO-K1 DUX B11 -- 275;
- Chinese hamster ovary (CHO) cells, CTLA4Ig-24 -- 123;
- Chinese hamster ovary (CHO) cells, K1 -- 155;
168;
168.5;
- Chinese hamster ovary (CHO) CHO-DND-3.alpha.3 cells -- 138;
142;
- Chinese ovary hamster (CHO) cells -- 148;
- Chinese ovary hamster (CHO) cells, 10A1C6 -- 148;
- Chinese ovary hamster (CHO) cells, DUKX-B11 -- 148;
- Chinese ovary hamster (CHO) cells, GD8/6 -- 148;
- Chinese ovary hamster (CHO) cells, MCB 9710 -- 148;
- chlortetracycline -- 529;
- CHO-DND-3.alpha.3 cells, Chinese hamster ovary (CHO) cells -- 138;
142;
- CHO-K1 cells -- 105;
- CHO-K1 DUX B11, Chinese hamster ovary (CHO) cells -- 275;
- cholera enterotoxin -- 653;
- chondrocytes, human -- 650;
650.3;
- Cibracon blue dye resin -- 105;
- citric acid -- 410;
- cleavable fusion expression -- 253;
- Clostridium botulinum type A, Hall Strain -- 602;
- Clostridium botulinum -- 413;
600;
601;
602.5;
603;
604;
911;
912;
- Clostridium botulinum toxins A, B, C, D, E and F -- 747;
- Clostridium hisolyticum -- 612;
- Clostridium tetani -- 421;
422;
423;
424;
425;
426;
427;
428;
429;
430;
431;
432;
433;
434;
435;
436;
437;
437.5;
439;
440;
440;
441;
442;
443;
444;
445;
446;
446.5;
447;
448;
449;
450;
451;
452;
455;
456.5;
459;
543;
544;
545;
546;
547;
548;
549;
550;
551;
552;
553;
554;
555;
556;
557;
558;
559;
786;
787;
- CMM1 (Cytogen), serum-free medium -- 312;
- CMV promoter -- 167.5;
- COBE Spectra Apheresis System -- 242;
- coenzyme A transferase -- 241;
- Cohn Fraction II -- 752;
775;
777;
- collagen matrix, bovine -- 651;
- collagen, bovine -- 656;
- collagen, porcine dermal -- 657;
- complement monoclonal antibody -- 120;
- Conn-Master 17633, vaccinia virus -- 537;
539;
540;
- copper -- 110;
- copperhead snake -- 153;
- coral snakes -- 910;
- Corynebacterium diphtheriae -- 418;
419;
420;
421;
422;
423;
424;
425;
426;
427;
428;
429;
430;
431;
432;
433;
434;
435;
436;
437;
437.5;
439;
440;
441;
442;
443;
444;
445;
446;
446.5;
447;
448;
449;
450;
451;
452;
454;
457;
502.5;
503;
513;
- Corynebacterium diphtheriae -- 513.3;
513.5;
555;
556;
557;
558;
559;
916;
- Costar cubes -- 464;
- costimulatory molecules (B7.1, ICAM-1 and LFA-3) -- 111;
- Cottonmouth venom -- 908;
- Crotalus adeamanteus venom -- 907;
- Crotalus atrox venom -- 907;
908;
- Crotalus durissus venom -- 907;
- Crotalus scutulatus venom -- 908;
- Cryoprecipitated AHF (antihemophilic factor) -- 722;
- CSL4S-342 Chinese hamster ovary (CHO) cells -- 105;
- CTAA16.88 cytokeratin tumor antigen -- 121;
- CTLA4Ig-24 Chinese hamster ovary (CHO) cells -- 123;
- culture, fungal -- 610;
- CVA vaccinia virus strain -- 541;
- CY medium -- 513;
- CY medium -- 513.3;
- cyclodextrin, methyl- beta- -- 430;
- CYT-063 monoclonal antibody -- 312;
- CYT-351 monoclonal antibody -- 312;
- Cytodex (microcarrier beads) -- 483.8;
- Cytodex 2 beads, microcarriers -- 187;
- cytomegalovirus (CMV) -- 748;
749;
- cytomegalovirus (CMV) major immediate early region 2 (IE2) mRNA -- 946;
- cytomegalovirus (CMV) promoter -- 141;
168;
168.5;
- cytomegalovirus (hCMV) promoter -- 261.7;
- cytotoxic T-lymphocyte-associated antigen 4 (CTLA4) -- 123;
123.5;
124;
125;
- Davis strain, cytomegalovirus (CMV) -- 748;
- DC5 (RT4376), Saccharomyces cerevisiae (yeast) strain -- 175;
177;
438;
441;
442;
463;
- deep cell culture (DCC) -- 794;
- dendritic cell vaccination -- 271;
- dendritic cells -- 416;
- dendritic cells, human -- 242;
- deoxycoformycin (dCF) -- 148;
- dextrose -- 562;
601;
- DG5.3, Chinese hamster ovary (CHO) cells -- 163;
- DI mouse strain -- 129;
- digoxin-albumin conjugate -- 913;
- dihydrofolate reductase (DHFR) -- 168;
168.5;
269;
- diol oxidoreductase -- 241;
- dipeptidyl aminopeptidase I -- 253;
- Diplococcus pneumoniae -- 406;
- Directed Molecular Evolution (DME) -- 246;
- DNA intercalation -- 803;
- Dryvax -- 788;
789;
790;
- DSM 3184 -- 166;
- Dubos medium -- 408;
- DUKX-B11 Chinese ovary hamster (CHO) cells -- 148;
- Dulbecco's Modified Eagle Medium (DMEM) -- 530;
- Dulbecco's Modified Eagles Medium (DMEM) -- 304;
312;
540;
650;
651;
656;
659;
- DXB-11 Chinese hamster ovary cells -- 267;
- E. coli maltose binding (MBP) protein-hyaluronidase fusion protein -- 186;
- E7.6.3 murine hybridoma cells -- 129;
- Eagle's Minimum Essential Medium -- 402;
403;
517;
521;
- Earle's balanced salt solution -- 521;
- ECACC 05030201 -- 796;
- ECACC V00083008 -- 541;
- ECACC V00120707 -- 541;
- Edmonston strain, measles virus -- 491;
492;
496;
- eggs, frog -- 628;
- elongation factor 1 alpha gene promoter -- 168;
168.5;
- Elstree-BN vaccinia virus strain -- 538;
- embryonic stem (ES) cells, murine -- 129;
- EMEM/NCTC medium -- 312;
- Ender strain, measles virus -- 491;
492;
493;
494;
496;
- eneticin sulfate -- 243;
- EpCAM -- 131;
131.5;
- epidermal growth factor -- 653;
- epidermal growth factor (EGF) receptor -- 130;
- epidermal growth factor receptor (EGFr) -- 128;
129;
244;
- epithelial cell adhesion molecule (EpCAM
131.5;
- epithelial cell growth factors -- 226;
- Epstein-Barr virus (EBV) transformed cells -- 121;
- equine plasma/serum -- 794;
907;
909;
910;
911;
912;
916;
918;
- Erwinia chrysanthemi -- 610;
- erythrocyte cell line, human -- 141;
162;
- Escherichia coli (E. coli -- 160.3;
- Escherichia coli (E. coli) -- 100;
103;
104;
106;
110;
158;
159;
160.1;
160.7;
160.8;
165;
170;
173;
192;
192.3;
192.5;
193.5;
194;
197;
198;
199;
201;
202;
204;
205;
206;
207;
208;
209;
212;
212.5;
213;
216;
219;
220;
226;
229;
230;
231;
234;
235;
236;
248;
249;
250;
251;
252;
253;
254;
255;
256;
258;
261.5;
263;
266;
268;
274;
415;
542;
608;
609;
611;
- Escherichia coli (E. coli) BL21 (.lambda.DE3) -- 217;
- Escherichia coli (E. coli) JM101 -- 220;
- Escherichia coli (E. coli) JM107 -- 214;
- Escherichia coli (E. coli) K-12 strain W3110 -- 202;
- Escherichia coli (E. coli) K12 -- 241;
- Escherichia coli (E. coli) K12/MM294-1 -- 218;
- Escherichia coli (E. coli) K802 -- 160.2;
160.9;
- Escherichia coli (E. coli) SGE90 -- 214;
- Escherichia coli (E. coli) strain RV308 -- 112;
- Escherichia coli (E. coli) strain SR1268 -- 260;
- ethanolamine -- 659;
- Eu human monoclonal antibody -- 222;
- Excell 302 medium -- 105;
- expresSF+
- expression, bacterial -- 103;
104;
112;
226;
266;
- expression, cleavable fusion -- 253;
- expression, human cells (gene activated) -- 141;
162;
188;
- expression, murine (mouse) cells -- 176;
- F8.1, murine monoclonal antibody -- 148;
- Factor VIII inhibitor bypassing activity -- 704;
- Factor Xa-complex cleavages -- 261;
- fascia -- 658;
- fed-batch system -- 245;
266;
- Fenton medium -- 436;
- Fer-de-lance -- 907;
- fermenters, 1,000 liter -- 268;
- fermenters, 500 L -- 415;
- fermenters, 550 L -- 415;
- ferrous sulfate -- 115;
- fetal bovine serum (FBS) -- 304;
532;
- fetal rhesus monkey diploid cells -- 224;
528;
532;
532;
- Fibra-Cel disks -- 232;
- fibroblast growth factor -- 226;
- fibroblasts, autologous -- 650.5;
- fibroblasts, guinea pig embryonic -- 494;
564;
- fibroblasts, human -- 162;
267;
651;
652;
657;
924;
- fibroblasts, MRC-5 human diploid -- 462;
463;
464;
465;
466;
518;
526;
539;
565;
- fibroblasts, WI-38 human diploid -- 402;
403;
494;
527;
533;
564;
- fibrosarcoma cells -- 167.5;
- filamentous hemagglutinin (FHA), Bordetella pertussis -- 440;
- Flavobacterium heparinum -- 924.5;
- Flury LEP (Low Egg Passage) C25, rabies virus -- 529;
- fms-like tyrosine kinase (FLT)-1 -- 949;
- folic acid -- 105;
656;
- fowlpox virus vector -- 111;
- Fraction II+III paste -- 620;
- FRhL diploid fetal rhesus lung cells -- 224;
- FRhL-2 diploid fetal rhesus lung cells -- 224;
528;
532;
- frog eggs -- 628;
- fusion proteins, recombinant -- 186;
202;
253;
259;
261.5;
- Ga-23-902-530 -- 209;
- GAGPL promoter -- 182;
- galactose -- 562;
- GBM strain, hepatitis A virus -- 465;
467;
- GD8/6 Chinese ovary hamster (CHO) cells -- 148;
- Gene Activation -- 141;
162;
- genetic diseases -- 188;
- geneticin -- 105;
- gentamicin (gentamycin) -- 114;
115;
179;
270;
402;
403;
653;
- GI-F8/1.5.6 murine hybridoma cells -- 147;
148;
719;
721;
722;
- glass beads -- 742;
- glucose -- 550;
601;
- glutamate -- 491;
504;
651;
- glutamine synthetase (GS) expression system -- 100;
115;
116;
118;
119;
179;
221;
222;
240;
245;
257;
264;
- glutamine, L- -- 105;
656;
659;
- glyceraldehyde-3-phosphate dehydrogenase (GAPDH) promoter -- 175;
- glycerin -- 410;
- glycerinated-water-potato medium -- 408;
409;
- glycine-extended precursor -- 110;
- glycine/hypoxanthine/thmidine (GHT)-free medium -- 275;
- glycogen degradation -- 168;
168.5;
- glycosaminoglycans (GAGs) degradation -- 105;
161;
167;
168;
168.5;
187;
188;
615;
- goat milk protein promoter gene -- 102;
- goats, transgenic -- 102;
123;
- guinea pig embryonic fibroblast cells -- 494;
564;
- Haemophilus influenzae type b -- 439;
440;
453;
454;
457;
458;
459;
- Haemophilus influenzae type b strain 20,752 -- 456.5;
- hair follicles, autologous -- 654;
- Hall strain, Clostridium botulinum -- 601;
- HAM's F-12 medium -- 651;
659;
- hamster, Chinese ovary (CHO) cells -- 142;
- Hank's medium (use Medium 199) -- 467;
- Harvard strain, Clostridium tetani -- 455;
- heat shock protein 90 -- 173;
- HEK 293 human embryonic kidney cells -- 232;
233;
243;
- HEK-293 cells -- 261.7;
261.7;
- Helix pomatia arylsulfatase -- 182;
- heparin resistance -- 102;
- hepatitis A virus (HAV) -- 461;
462;
464;
465;
- hepatitis A virus (HAV) HM-175 strain -- 463;
466;
- hepatitis A virus GBM strain -- 465;
467;
- hepatitis A virus RG-SB strain -- 462;
- hepatitis B virus (HBV) -- 174;
175;
176;
177;
178;
428;
438;
439;
440;
441;
442;
452;
468;
567;
- hepatitis B virus subtype adw2 -- 175;
177;
438;
441;
442;
- hepatitis B virus surface antigen (HBsAg) -- 174;
175;
176;
177;
178;
460;
466;
468;
469;
- hepatitis B virus surface antigen terminator -- 269;
- HEPES buffer -- 656;
- HER1 -- 128;
- Herpes simplex virus thymidine kinase
- hexametaphosphate -- 415;
- Hi-5 Rix4446 cells -- 185;
- High Five cell line -- 185;
271;
- high molecular weight-melanoma-associated antigen (HMW-MAA) -- 309;
- high-calcium medium -- 651;
- hirudin variant I (HVI) -- 182;
- Hirudo medicinalis (medicinal leech) -- 180;
181;
182;
- HIV -- 516;
521;
- HIV-1 gp41 glycoprotein -- 933;
- HM-175, hepatitis A virus strain -- 463;
466;
- Holt's media, modified -- 514;
- honey bee melittin secretory signal sequence -- 271;
- hP67.6, monoclonal antibody -- 118;
- HSP90 -- 173;
- HSV 1-TK cDNA--simian virus 40 (SV40) polyadenylation signal
- HT-1080 human cells -- 167.5;
- HuMAb-Mouse -- 116.5;
222.4;
265.5;
- HuMAb-Mouse transgenic mice -- 214.5;
- human cells HT-1080 -- 167.5;
- human cells R223 -- 141;
- human cells, chondrocytes -- 650;
650.3;
- human cells, lymphoblastoid -- 121;
- human cells, mesenchymal stem cells (MSCs) -- 649;
- human cells, unspecified -- 265;
- human cells/tissues sources -- 263;
- human cytomegalovirus (hCMV) promoter -- 261.7;
- human diploid cells -- 494.5;
495;
774;
- human diploid fibroblast cells, MRC-5 -- 565;
- human embryonic cells -- 489;
- human embryonic kidney (HEK 293) cells -- 232;
233;
243;
- human embryonic kidney (HEK-293) cells -- 261.7;
- human embryonic lung cells -- 494;
564;
- human epidermal and dermal cells -- 656;
- human fibroblast cells -- 267;
462;
464;
465;
651;
652;
- human keratinocytes -- 651;
653;
654;
656;
- human kidney cells, neonatal -- 626;
627;
- human leukocytes -- 795;
796;
- human lymphoblastoid cells -- 794;
- human neonatal foreskins -- 651;
652;
656;
657;
- human P3x63Ag8.653 myeloma cells -- 312;
- human papillomavirus (HPV) type 11 L1 virus-like particles (VLPs) -- 183;
184;
185;
- human placental tissue -- 615;
- human Rho(D) cells -- 776;
777;
778;
779;
780;
- human rotavirus P1A -- 531;
- human rotavirus stain W179 -- 531;
- human thymus lymphocytes (T-cells) -- 917;
918;
- human tissues -- 652;
- human transferrin -- 651;
- human-bovine reassortant viruses -- 531;
- human-rhesus rotavirus reassortant virus serotypes 1, 2, and 4 -- 532;
- hyaluronidase-E. coli maltose binding (MBP) protein fusion protein -- 186;
- hybridoma 3-A3-2 -- 796;
- hydridoma, murine Sp2/0-Ag14 -- 214.5;
- hydrocortisone -- 651;
653;
659;
- hypoxanthine, glycine, and thymidine (HGT) medium -- 269;
- IMMU-4 hybridoma, murine -- 304;
307;
- immune globulin (IgE) -- 189;
- inase insert domain-containing region (KDR) -- 949;
- influenza A/California/07/2009 (H1N1) virus -- 483.8;
- influenza A/California/7/2009 (H1N1)v -- 191.1;
- influenza A/California/7/2009 (H1N1)v -- 483.11;
- influenza A/California/7/2009 (H1N1)v -- 483.7;
- influenza A/California/7/2009 (H1N1)v NYMC X-179A virus -- 483.7;
- influenza A/California/7/2009 (H1N1)v-like virus -- 483.1;
- influenza A/California/7/2009 (H1N1)v-like virus -- 483.2;
- influenza A/California/7/2009 (H1N1)v-like virus -- 483.3;
- influenza A/California/7/2009 (H1N1)v-like virus -- 483.4;
- influenza A/California/7/2009 (H1N1)v-like virus -- 483.8;
- influenza A/Viet Nam/1194/2004 (H5N1) NIBRG-14 virus -- 483.7;
- influenza NIBRG-14 virus -- 483.7;
- influenza polymerase Basic Protein 2 (PB2) gene -- 190;
- influenza strain A/Viet Nam/1194/2004 (H5N1) -- 487;
- influenza virus -- 190;
191.5;
470;
471;
472;
473;
474;
475;
476;
477;
478;
479;
480;
481;
483;
- influenza virus -- 483.2;
- influenza virus -- 483.3;
- influenza virus A/Indonesia) (H5N1, clade 2)
- influenza virus A/Vietnam/1203/2004 (H5N1, clade 1)
- influenza virus H5N1 Reverse Genetics Strain NIBRG 14 -- 487;
- influenza virus, cold-adapted -- 191;
486;
- influenza virus, H5N1 -- 484;
485;
486;
487;
488;
- insulin, bovine -- 651;
659;
- insulin, recombinant -- 481;
653;
- insulin, recombinant human -- 150;
150.5;
245;
- integrin alpha(4) receptors -- 203;
- intercellular adhesion molecule-1 (ICAM-1) -- 114;
- interleukin-12 (IL-12)
- interleukin-13 (IL-13) -- 217;
- interleukin-23 (IL-23)
- interleukin-6 receptors (IL-6r) -- 223;
- irculating immune complexes (CICs) -- 700;
- iron ammonium citrate -- 410;
- IscoveÕs medium -- 168;
168.5;
- isopropyl-beta-D- thiogalactopyranoside (IPTG) -- 120;
260;
266;
- IVI-10028 -- 110;
- Japanese encephalitis virus -- 224;
489;
- Japanese encephalitis virus (JE) prM -- 224;
- Jeryl Lynn strain, mumps virus -- 492;
493;
494;
504;
534;
- JM101, Escherichia coli (E. coli) -- 220;
- JM107, Escherichia coli (E. coli) -- 214;
- JRH Excell 302 medium -- 105;
105;
- K-12 strain W3110, Escherichia coli (E. coli) -- 202;
- K-12, Escherichia coli (E. coli) -- 192;
197;
213;
268;
- K1 Chinese hamster ovary (CHO) cells -- 155;
168;
168.5;
- K12/MM294-1, E. coli -- 218;
- kanamycin sulfate -- 230;
- keratinocytes, human -- 651;
653;
654;
656;
- kidney (HEK 293) cells, human embryonic -- 232;
243;
- kidney cells, baby hamster -- 122;
145;
149;
151;
- kidney cells, canine Madin-Darby (MDCK) -- 483;
- kidney cells, human embryonic -- 232;
233;
243;
- kidney cells, human neonatal -- 626;
627;
- kidney cells, monkey -- 224;
490;
516;
517;
520;
521;
530;
531;
532;
540;
- kifunensine -- 167.5;
- Klebsiella pneumoniae -- 406;
- KMAC-43 vector -- 206;
- KSSKC epitope -- 120;
- lacI9 gene (Amersham) -- 220;
- lacIq gene -- 266;
- lactalbumin hydrolysate -- 520;
521;
- lactose -- 500;
- Latrodectus mactans -- 909;
- leeches, medicinal -- 180;
181;
182;
- leopard frog -- 628;
- leukocyte function antigen-1 (LFA-1) -- 114;
- leukocyte removal -- 806;
- leukocytes, human -- 242;
795;
796;
- lung cell cultures, human embryonic -- 564;
- lymphoblastoid cell line SB -- 117;
- lymphoblastoid cells, human -- 121;
794;
- lymphocytes, B-cells -- 271;
417;
- lymphocytes, human -- 115;
203;
222;
303;
917;
918;
- M9 minimal medium -- 220;
- MA-104 cells -- 530;
- Mab 1129, murine monoclonal antibody -- 245;
- Madin-Darby canine kidney cells (MDCK) -- 483;
- magnesium sulfate -- 410;
- maltose binding (MBP) protein, E. coli -- 186;
- mammalian cell culture -- 100;
109;
114;
115;
116;
116.5;
118;
119;
121;
124;
125;
126;
128;
131;
131.5;
133;
136;
141;
143;
144;
145;
146;
147;
148;
149;
150;
150.5;
151;
152;
155;
156;
163;
167;
167.5;
172;
176;
179;
187;
189;
202;
203;
210;
211;
222;
222.4;
222.6;
223;
224;
227;
240;
242;
244;
245;
246;
257;
261;
262;
264;
267;
269;
270;
302;
303;
304;
305;
307;
309;
310;
311;
312;
313;
314;
315;
402;
403;
462;
463;
464;
466;
481;
483;
491;
492;
493;
493.5;
494;
496;
504;
517;
518;
519;
520;
521;
522;
523;
524;
526;
527;
528;
529;
530;
531;
532;
533;
534;
538;
539;
540;
541;
564;
565;
567;
626;
627;
650;
650.3;
650.5;
651;
652;
653;
654;
656;
657;
659;
794;
- mannose-6-phosphate (M6P) ligands -- 168;
168.5;
- mannose-6-phosphate receptors -- 105;
- MCB 9710 Chinese ovary hamster (CHO) cells -- 148;
- ME1719, Saccharomyces cerevisiae (yeast) strain -- 166.5;
- measles virus Schertz strain -- 493.5;
- measles virus Schwarz strain -- 495;
- measles virus, Edmonston strain -- 491;
492;
493;
494;
- measles virus, Ender strain -- 491;
492;
493;
494;
496;
- media, AIM -- 242;
- media, defined nutrient -- 206;
457;
- media, semi-synthetic -- 455;
550;
561;
- media, serum-based -- 150;
- media, serum-free -- 105;
108;
115;
129;
179;
242;
275;
314;
540;
653;
732;
- Medium 199 -- 446.5;
- Medium 199 (M-199; Hank's medium) -- 440;
441;
442;
465;
467;
491;
504;
516;
517;
- megakaryocytes -- 216;
802;
- melittin secretory signal sequence -- 271;
- membrane translocation -- 217;
- mesenchymal stem cells (MSCs) -- 649;
- mice -- 264;
303;
304;
489;
- mice, Viral Antigen Free -- 304;
- Microbial Surface Components Recognizing Adhesive Matrix Molecules -- 783;
- microcarrier beads -- 483.8;
- microcarrier culture -- 145;
187;
211;
517;
518;
519;
520;
530;
- Microgen Fermentor (New Brunswick Scienctific) -- 220;
- Micromonaspora echinospora -- 118;
- Micrurus fulvius -- 910;
- mineral salts -- 550;
- minimally supplemented basal medium (MSBM) -- 651;
659;
- Minimum Essential Medium (MEM) -- 532;
533;
656;
- MM 294-1/pLW 45, Escherichia coli (E. coli) -- 218;
- Modified Vaccinia Ankara (MVA) strain vaccinia virus -- 541;
- Mojave rattlesnake venom -- 908;
- monkey cells -- 245;
- monkey diploid cells, fetal rhesus -- 528;
528;
532;
532;
- monkey diploid cells -- 224;
- monkey kidney cells -- 440;
440;
516;
517;
519;
520;
521;
530;
532;
540;
- monoclonal antibodies -- 309;
- monoclonal antibody VEGF Mab A.4.6.1 -- 275;
- monoclonal antibody, murine -- 117;
306;
- monoclonal antiibody, murine-rat chimeric -- 131;
- monocytes -- 742;
- Moraxella catarrhalis -- 406;
- mouse strain, DI -- 129;
- MRC-5 cells -- 445;
- MRC-5 human diploid fibroblast cells -- 462;
463;
464;
465;
494;
518;
526;
527;
539;
564;
565;
- MSCRAMM , Staphylococcus aureus -- 783;
- MTT cell assay -- 652;
- mucin-1 (MUC-1) gene -- 111;
- Mueller and Miller medium -- 424;
426;
430;
431;
435;
443;
447;
449;
451;
454;
455;
547;
552;
555;
556;
559;
916;
- Mueller Hinton agar -- 498;
499;
500;
502;
- Mueller medium -- 430;
- mumps virus -- 932;
- mumps virus Jeryl Lynn strain -- 492;
493;
493.5;
494;
504;
534;
- murine (mouse) cell line -- 176;
- murine (mouse) hybridoma cells -- 117;
129;
240;
264;
301;
303;
305;
306;
309;
310;
311;
314;
315;
701;
- murine (mouse) hybridoma, 225.28S -- 309;
- murine ascites -- 302;
303;
304;
307;
309;
314;
701;
804;
- murine brains -- 489;
- murine embryonic stem (ES) cells -- 129;
- murine feeder cells -- 264;
653;
- murine hybridoma cells, 225 -- 128;
- murine hybridoma cells, B431.13 -- 301;
- murine hybridoma E7.6.3 -- 129;
- murine hybridoma GI-F8/1.5.6 -- 147;
148;
721;
722;
- murine monoclonal antibody, 5G1.1 -- 120;
- murine myeloma cells -- 120;
128;
176;
203;
221;
240;
244;
245;
264;
313;
315;
721;
- murine parainfluenza virus type 1 (Sendai strain) -- 794;
- murine Sp2/0-Ag14 hydridoma -- 214.5;
- murine tumor cells C-127 (C127) -- 257;
- murine-rat chimeric monoclonal antibody -- 131;
- muscle fascia -- 658;
- MVA 572 -- 541;
- MVA 572 FHE - 22.02.1974 -- 541;
- MVA strain vaccinia virus -- 541;
- MY-10 (MY10) murine hybridoma cells -- 701;
- Mycobacterium bovis -- 407;
409;
410;
- Mycobacterium bovis (Bacillus of Calmette and Guerin strain), live -- 408;
411;
412;
- myeloma cell line P3-X-63-AG8-653
- myeloma cells, murine -- 128;
264;
- myeloma cells, P3-NS-1-Ag4 -- 315;
- myeloma cells, P3X63Ag8Ul -- 303;
- MYPPPY motif -- 123;
- NakayamaÐNIH strain, Japanese encephalitis virus -- 489;
- Namalva cells -- 794;
- Neisseria catarrhalis -- 406;
- Neisseria meningitidis -- 452;
497;
502.5;
503;
- Neisseria meningitidis B11 strain -- 458;
- Neisseria meningitidis group A-1 -- 498;
499;
- Neisseria meningitidis group C -- 500;
501;
- Neisseria meningitidis group C-11 -- 499;
- Neisseria meningitidis group W-135-6308 -- 502;
- neomycin -- 119;
220;
402;
403;
481.5;
491;
504;
517;
521;
527;
529;
532;
- neomycin phosphotransferase marker gene -- 105;
- neomycin sulfate -- 441;
- New York City Board of Health (NYCBH) vaccinia virus -- 111;
536;
537;
539;
540;
- NIBRG-14, influenza A/Viet Nam/1194/2004 (H5N1) virus -- 483.7;
- NIBSC 84/703 -- 262;
- North American coral snake -- 910;
- NR-LU-10 murine hybridoma cells -- 311;
- NS-1 murine myeloma cells -- 313;
- NS0 mammalian cell line -- 118;
245;
246;
- NS0 murine meloma cells -- 120;
- Nunc cell factories -- 464;
539;
- NZ (or N-Z) Amine A -- 601;
- O-phosphorylethanolamine -- 651;
- Oka/Merck, varicella-zoster virus strain -- 564;
565;
- OmpA signal -- 266;
- osteosarcoma cells -- 108;
- ovine blood infusion media -- 406;
- ovine testes -- 619;
- P-3Ag 8653 murine myeloma cells -- 721;
- p15A, plasmid -- 266;
- P1A, human rotavirus -- 531;
- P3-NS-1-Ag4 myeloma cells -- 315;
- P3-X-63-AG8-653, myeloma cell line -- 804;
- P3x63Ag8.653 myeloma cells -- 312;
- P3X63Ag8Ul myeloma cells -- 303;
- p40, interleukin-12 (IL-12) and interleukin-23 (IL-23)
- p53, adenovirus vector gene therapy -- 232;
233;
- p7E3VHhCg4 -- 240;
- p7E3VkhCk -- 240;
- pAdCMVTK plasmids -- 261.7;
- pAdenogal plasmids -- 261.7;
- papaya -- 622;
- pAPEX-3p, plasmid -- 120;
- parainfluenza virus type 1, murine -- 794;
- parallel-plate bioreactor (PPB) -- 539;
- Park-William no. 8, Corynebacterium diphtheriae -- 419;
- pAS1 plasmid -- 230;
- pAT153 plasmid -- 112;
- pC4 plasmids -- 208.5;
- pCAV/NOT-TNFR -- 267;
- pCAVDHFR -- 267;
- pCAVDHFRhuTNFRFc -- 267;
- pcDNAI/Amp (Invitrogen) plasmid -- 120;
- pDD6 plasmid -- 214;
- pDP34, yeast shuttle vector -- 182;
- pDR2 (Clontech) plasmid -- 120;
- pDW24 plasmid -- 220;
- pDW27 plasmid -- 220;
- pEE12.1, plasmids -- 208.5;
- penicillin -- 653;
- pepticase -- 196;
- peptidase -- 182;
- peptidyl-glycine alpha-amidating monooxygenase (PAM) -- 110;
- peptone (medium) -- 182;
196;
270;
406;
424;
431;
443;
447;
513;
- peptone (medium) -- 513.3;
544;
549;
550;
555;
556;
563;
- pER10088 plasmid -- 202;
- perfusion bioreactors -- 105;
119;
163;
232;
240;
264;
312;
409;
539;
540;
- periosteum -- 650;
- pET Trc SO5/NI plasmid -- 120;
- pFE4S plasmid -- 105;
- pGB20, pGB37 and pGB42 plasmids -- 167;
- PH05 signal sequence -- 182;
- PHA synthetase -- 241;
- phage display -- 119;
225;
265;
- phage T4 -- 260;
- phiX-174 -- 779;
- phosphorylethanolamine -- 659;
- photoactivation, antibody -- 301;
- pHuGTAC1 plasmid -- 222;
- phuIL13-Tx plasmid -- 217;
- pHuLTAC plasmid -- 222;
- Pichia pastoris (yeast) expression -- 153;
225;
- pit vipers -- 907;
- pIXY15 plasmid -- 169;
- pIXY498 plasmid -- 267;
- pKV308 plasmid -- 166.5;
- placental tissue, human -- 615;
- plant cell culture -- 167.3;
- pLAPC, plasmid -- 243;
- Plasma -- 742;
- plasma, equine -- 907;
909;
910;
912;
916;
918;
- plasma, human media component -- 149;
151;
- plasmid p15A -- 266;
- plasmid p7E3VkappahCkappa -- 240;
- plasmid pAPEX-3p -- 120;
- plasmid pAS1 -- 230;
- plasmid pAT153 -- 112;
- plasmid pCAV/NOT-TNFR -- 267;
- plasmid pCAVDHFR -- 267;
- plasmid pCAVDHFRhuTNFRFc -- 267;
- plasmid pcDNAI/Amp (Invitrogen) -- 120;
- plasmid pDD6 -- 214;
- plasmid pDP34/GAPFL-YHIR -- 182;
- plasmid pDR2 (Clontech) -- 120;
- plasmid pDW24 -- 220;
- plasmid pDW27 -- 220;
- plasmid pER10088 -- 202;
- plasmid pET Trc SO5/NI -- 120;
- plasmid pFE4S -- 105;
- plasmid pGB20, pGB37 and pGB42 -- 167;
- plasmid pHuGTAC1 -- 222;
- plasmid phuIL13-Tx -- 217;
- plasmid pHuLTAC -- 222;
- plasmid pIXY15 -- 169;
- plasmid pIXY498 -- 267;
- plasmid pKV308 -- 166.5;
- plasmid pLAPC -- 243;
- plasmid pLPC -- 243;
- plasmid pLW45 -- 218;
- plasmid pNM21 -- 112;
- plasmid pOA15 -- 230;
- plasmid pRK -- 269;
- plasmid pTACdenV -- 260;
- plasmid pTTO -- 266;
- plasmid, Bluescript (Stratagene) -- 267;
- plasmid, ptPA/DHFR -- 269;
- plasmids, pAdCMVTK -- 261.7;
- plasmids, pAdenogal -- 261.7;
- plasmids, PC4 -- 208.5;
- plasmids, pEE12.1 -- 208.5;
- plasmids, pPPC0005
- plasmids, pSAC35 -- 208.5;
- Platelets -- 803;
- pLPC, plasmid -- 243;
- pM2/alpha vector -- 122;
- pMT612 -- 166;
- pNM21 plasmid -- 112;
- pOA15 plasmid -- 230;
- poliomyelitis virus -- 446;
- poliovirus type 1 -- 439;
440;
441;
442;
517;
518;
519;
521;
522;
- poliovirus type 2 -- 439;
440;
441;
442;
521;
523;
- poliovirus type 3 -- 439;
440;
441;
442;
521;
524;
- polycarbonate molds -- 651;
- polyethyleneimine -- 202;
- polyglactin matrix -- 652;
- polyglycolic acid matrix -- 652;
- polyhedrin promotor -- 271;
- polymyxin B -- 441;
- porcine dermal collagen -- 657;
- porcine endogenous retroviruses (PERV) -- 901;
- porcine lung surfactant -- 943;
- porcine pancreas -- 632;
633;
- porcine parvovirus (PPV) -- 901;
- porcine teeth -- 931;
- porphobilinogen deaminase -- 716;
- potassium phosphate -- 410;
- potato medium, glycerinized -- 408;
- poxvirus vectors, vaccinia -- 111;
- pPPC0005, plasmids -- 208.5;
- preproinsulin 5Õ UTR, rat -- 105;
- prethrombin-1 precursor -- 261;
- pRIT12363 plasmid -- 175;
- pRK plasmid -- 269;
- ProCellEx expression system -- 167.5;
- protease inhibition -- 105;
- Protein A affinity chromatography -- 129;
- Protein C zymogen -- 243;
804;
- prothrombin, gla-domainless -- 261;
- pSAC35
- Pseudomonas aeruginosa -- 542;
- Pseudomonas aeruginosa exotoxin AÐN-succinimidyl 3-(-2-pyridyldithio)propionate -- 542;
- Pseudomonas exotoxin (PE38) -- 217;
- Pseudomonas sp. strain RS-16 -- 112;
- pTACdenV plasmid -- 260;
- ptPA/DHFR plasmid -- 269;
- pTTO plasmid -- 266;
- Puziss-Wright 1095 -- 404;
- PYinsl yeast cells -- 193;
- pyrimidine dimer DNA glycosylase -- 260;
- quadroma -- 131.5;
- quadromas -- 131;
- R223 human cells -- 141;
- RA 27/3 Wistar Inst. strain, rubella virus -- 493;
494;
496;
533;
534;
- RA27/3 strain, rubella virus -- 494.5;
495;
- rabbits -- 917;
- rabbits, transgenic -- 113;
168;
- rabies vaccine -- 774;
775;
- rabies virus -- 528;
- rabies virus strain CL-77 -- 526;
- rabies virus strain Flury LEP (Low Egg Passage) C25 -- 529;
- rabies virus strain Kissling -- 528;
- rabies virus strain Pitman-Moore PM-1503-3M -- 527;
- rabies virus strain SAD (Street Alabama Dufferin) -- 526;
- Rana pipiens -- 628;
- RANKL -- 244;
- rat medullary thyroid carcinoma cells -- 110;
- rat preproinsulin 5Õ UTR gene -- 105;
- rat-murine chimeric monoclonal antibody -- 131;
- rattlesnakes -- 907;
908;
- reassortant viruses -- 486;
- Receptor Activator of NF-KB -- 244;
- Red Blood Cells (erythrocytes) -- 716;
- respiratory syncytial virus (RSV) F protein -- 246;
- respiratory syncytial virus (RSV) fusion (F) protein -- 245;
- retroviruses, porcine endogenous -- 901;
- reverse genetics -- 486;
- RG-SB strain, hepatitis A virus -- 462;
- rhesus lung cells, diploid fetal -- 224;
528;
532;
532;
- rhesus rotavirus (serotype 3) -- 532;
- rhesus-human rotavirus reassortant virus serotypes 1, 2, and 4 -- 532;
- Rho(D) (D-positive) red blood cells -- 776;
777;
778;
779;
- RNA intercalation -- 803;
- rodent cells -- 109;
115;
116;
116.5;
118;
126;
133;
134;
135;
136;
137;
139;
140;
144;
145;
146;
147;
149;
150;
151;
152;
155;
156;
163;
167;
179;
187;
189;
210;
211;
221;
222;
227;
228;
240;
257;
262;
264;
267;
269;
270;
275;
302;
303;
304;
305;
307;
310;
311;
312;
313;
313;
314;
315;
- roller bottles -- 143;
162;
304;
464;
- rotavirus -- 532;
- rotavirus 89-12C2 -- 530;
- rotavirus stain BrB, human -- 531;
- RPMI 1640 -- 794;
- rubella virus Wistar Inst. RA 27/3 strain -- 493;
493.5;
494;
494.5;
495;
496;
533;
534;
- RV308, Escherichia coli (E. coli) strain -- 112;
- SA14-14-2, Japanese encephalitis virus -- 224;
490;
- Saanen
- Saccharomyces cerevisiae (yeast) -- 100;
101;
166;
169;
181;
182;
184;
193;
195;
196;
200;
208.5;
228;
237;
238;
239;
248;
272;
439;
440;
465;
466;
629;
- Saccharomyces cerevisiae (yeast) 1454 cells -- 182;
- Saccharomyces cerevisiae (yeast) strain 2150-2-3 -- 174;
175;
178;
- Saccharomyces cerevisiae (yeast) strain DC5 (RT4376) -- 175;
177;
438;
441;
442;
463;
- Saccharomyces cerevisiae (yeast) strain ME1719 -- 166.5;
- Saccharomyces cerevisiae (yeast) strain YES2085 -- 166.5;
- Saccharomyces cerevisiae MF.alpha.1 signal sequence -- 261;
- Saccharomyces cerevisiae spheroplasts -- 129;
- Salmonella minnesota -- 938;
- Salmonella typhi -- 560;
562;
563;
- Salmonella typhi Vi (Ty 2 strain) -- 467;
561;
- Sauton medium -- 409;
- SB, lymphoblastoid cell line -- 117;
- Schertz strain, measles virus -- 493.5;
- Schwarz strain, measles virus -- 495;
- SelectAME -- 246;
- selenious acid -- 651;
659;
- semialdehyde dehydrogenase -- 241;
- Sendai virus -- 794;
795;
796;
- serine -- 105;
- Serratia marcescens endonuclease -- 539;
540;
- Serum (Human), immunoglobulin-depleted -- 795;
- serum, fetal calf -- 105;
140;
402;
403;
652;
- SF9 cells -- 191.5;
- SGE90, Escherichia coli (E. coli) -- 214;
- silica (diatomaceous earth) -- 700;
- simian immunodeficiency virus (SIV) -- 516;
- simian virus 40 (SV40) -- 516;
519;
- skin cells, human -- 656;
- snake venoms -- 907;
908;
910;
- sodium bicarbonate -- 656;
659;
- sodium hexametaphosphate -- 415;
- sooty mangabey kidney cells -- 516;
- Source Leukocytes -- 795;
- Souton medium -- 408;
- soy peptone -- 182;
513;
- soy peptone -- 513.3;
- Sp2/0 murine hybridoma/myeloma cells -- 117;
222;
240;
264;
- SP2/Ag14 cells -- 130;
- SPGA (sucrose, phosphate, glutamate, albumin) -- 491;
504;
- spheroplasts, Saccharomyces cerevisiae (yeast) -- 129;
- spider venom, black widow -- 909;
- Spodoptera frugiperda Sf21 -- 242;
- Spodoptera frugiperda Sf9 caterpillar cells -- 191.5;
- SR1268, Escherichia coli (E. coli) strain -- 260;
- Stainer-Scholte medium -- 430;
431;
436;
507;
508;
- Stainer's Diphtheria Culture Medium -- 420;
- Staphylococcus aureus -- 542;
700;
- Staphylococcus aureus MSCRAMM proteins -- 783;
- Staphyloococcus aureus -- 406;
- stem cells, mesenchymal -- 649;
- Sterile Water for Injection -- 659;
- stirred-tank, fed-batch system -- 245;
- stratum corneum, human -- 651;
- Streptocccus pneumoniae -- 406;
- Streptococcus bacteria -- 929;
- Streptococcus pneumoniae -- 512;
513;
- Streptococcus pneumoniae -- 513.3;
513.5;
514;
515;
- Streptococcus viridans -- 406;
- Streptococcus, group C beta-hemolytic -- 606;
624;
625;
- Streptomyces lividans -- 171;
- streptomycin -- 517;
521;
653;
- stroma -- 652;
657;
- suspension cell culture -- 115;
179;
- SV-40 promoter -- 269;
- SV40 origin of replication -- 105;
- T-Flask culture -- 245;
- T4 bacteriophage -- 260;
- TAC promoter -- 260;
266;
- tanks, 8,000 Liter -- 794;
- Taxus media -- 703.5;
- teeth, porcine -- 931;
- tetanus toxin -- 784;
- tetracycline -- 204;
- tetracycline resistance gene -- 266;
- tetramethylurea -- 794;
- tetrazolium -- 652;
- TFF-Cell Separation System -- 416;
- thioredoxin/interleukin-11 fusion protein -- 221;
- three-demensional cell culture -- 651;
- thymine -- 220;
- thymocytes, human -- 917;
918;
- tissue culture, three-dimensional -- 651;
652;
657;
- tissue plasminogen activator leader sequence -- 261;
- TNF40 murine (mouse) monoclonal antibody -- 266;
- Toggenburg
- Tohama strain, Bordetella pertussis -- 508;
- toxin production medium (TPM) -- 601;
- transferrin, bovine -- 115;
162;
245;
312;
- transferrin, human -- 651;
659;
- transgenic goats -- 102;
123;
- transgenic mice -- 116.5;
222.4;
265.5;
- transgenic rabbits -- 113;
168;
- transgenic XenoMouse mice -- 129;
- trc promoter -- 220;
- Trichopulsia ni High Five cells -- 185;
271;
- TRICOM -- 111;
- triiodothyronine -- 651;
653;
659;
- trioma -- 131.5;
- tris (tromethamine) -- 197;
- trypsin -- 483.8;
- trypsin -- 565;
- trypticase soy agar medium -- 414;
- tumor cells -- 417;
- tumor-associated antigen, CA125 -- 301;
- tumor-associated glycoprotein-72 (TAG-72) -- 315;
- two-chain expression method -- 192;
- ubiquitin protein peptidase -- 202;
- Ubiquitous Chromatin Opening Element -- 149;
- UCOE -- 149;
- UltiMAb -- 116.5;
222.4;
- UltiMAb HuMAb-Mouse transgenic mice -- 214.5;
- vaccinia virus -- 535;
- vaccinia virus Conn-Master 17633 strain -- 537;
- vaccinia virus strain, CVA -- 541;
- vaccinia virus strain, Elstree-BN -- 538;
- vaccinia virus strain, Modified Vaccinia Ankara (MVA) -- 541;
- vaccinia virus vaccine -- 788;
789;
790;
- vaccinia virus, New York City Board of Health (NYCBH) -- 111;
536;
537;
539;
540;
- vancomycin -- 653;
- Varicella Virus Vaccine -- 791;
792;
- varicella-zoster virus strain Oka/Merck -- 564;
565;
- Variovorax paradoxus -- 112;
- vascular endotelial growth factor (VEGF) -- 949;
- vascular endothelial cell growth factor (VEGF) -- 275;
276;
- veal infusion agar -- 563;
- VEGF Mab A.4.6.1 monoclonal antibody -- 275;
- VEGF-165 -- 949;
- Vero cells -- 224;
437.5;
440;
445;
445;
446.5;
- Vero cells -- 483.8;
490;
517;
520;
530;
531;
540;
- vesicular stomatitis virus (VSV) -- 211;
796;
- Vibrio cholerae Inaba (NIH 35A3) -- 414;
- Vibrio cholerae O1 Inabo, classic -- 415;
- Vibrio cholerae O1 Inabo, El Tor -- 415;
- Vibrio cholerae O1 Oqawa, classic -- 415;
- Vibrio cholerae O1 Oqawa, El Tor -- 415;
- Vibrio cholerae Ogawa (NIH 41) -- 414;
- Vicryl polymer matrix -- 652;
- Viral Antigen Free mice -- 304;
- viral inactivation, detergent -- 475;
- virus culture -- 176;
183;
- virus culture -- 191.1;
229;
462;
463;
464;
465;
470;
471;
472;
473;
474;
475;
476;
477;
478;
479;
480;
481;
481.5;
482;
483;
- virus culture -- 483.1;
- virus culture -- 483.11;
- virus culture -- 483.2;
- virus culture -- 483.3;
- virus culture -- 483.7;
- virus culture -- 483.8;
484;
485;
486;
487;
488;
489;
491;
492;
493;
494;
494.5;
495;
496;
504;
533;
534;
536;
537;
538;
539;
540;
541;
564;
565;
566;
567;
- virus inactivation, beta-propriolactone -- 481;
- virus vector, fowlpox -- 111;
- virus vector, vaccinia virus -- 111;
- VLA-4 -- 203;
- W179, human rotavirus stain -- 531;
- WAG/Rij rat medullary thyroid carcinoma cells -- 110;
- water moccasin venom -- 907;
908;
- Watson Scherp media -- 498;
499;
500;
502;
- WC-3, bovine rotavirus -- 531;
- WC-3, bovine rotavirus G6 strain -- 531;
- WI-38 human diploid fibroblasts -- 402;
403;
494;
527;
533;
564;
- WISH cells -- 211;
- Wistar Calf-3 (WC3), bovine rotavirus stain -- 531;
- XenoMouse, transgenic -- 129;
- XV2181, Saccharomyces cerevisiae (yeast) strain -- 169;
- yeast 2µ plasmid -- 196;
- yeast acid phosphatase (PH05) -- 182;
- yeast artificial chromosome (YAC) vectors -- 129;
- yeast extract -- 406;
457;
601;
- yeast shuttle vector pDP34 -- 182;
- yellow fever virus strain 17D -- 566;
567;
- yellow fever virus strain 17D vector -- 224;
- Yersinia pestis (plague bacteria) -- 511;
- YES2085, Saccharomyces cerevisiae (yeast) strain -- 166.5;
- ZS7, Borellia burgdorferi -- 230;
- 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide -- 205;
- 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) -- 542;
- 1,4-butandiol diglycidylether (BDDE) -- 929;
- 2-deoxyinosine -- 605;
- 2-ethoxyethanol -- 621.5;
- 2-phenoxyethanol -- 230;
423;
430;
433;
437;
437.5;
441;
442;
445;
446.5;
463;
465;
466;
467;
517;
- 2,3-diphosphoglycerate (2,3-DPG) -- 806;
- 2,3,5,6-tetrafluorophenyl-4,5-bis-S-(1-ethoxyehtyl)-thioacetoamidopentoate) -- 311;
- 2.2.9 monoclonal antibody -- 147;
- 2'-deoxyadenosine (DDA) -- 605;
- 3-((2-aminoethoxy)methyl)-2,5,9-trimethyl-7H-furo(3,2-g)(1)benzopyran-7-one -- 803;
- 3-A3-2, monoclonal antibody -- 796;
- 3-beta-D-ribosyl(1-1)ribitol(5-phosphate)-PRP -- 457;
- 3-deacylated monophosphoryl lipid A -- 177;
185;
- 3F-concentrate -- 732;
- 4-acetylphenylacetic acid -- 118;
- 4-deoxy-4-amino-N10-methylpteroic acid (DAMPA) -- 112;
- 4-methylumbelliferyl sulphate -- 105;
- 4-methylumbelliferyl-a-iduronide -- 187;
- 5 ,20-Epoxy-1,2 ,4,7 ,10 ,13 -hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine -- 703.5;
- 8A4 Sepharose -- 150;
- Absorbable Gelatin Sponge, USP -- 920;
- acellular Pertussis Vaccine -- 437.5;
444;
445;
446;
- acetic acid -- 110;
181;
205;
212;
212.5;
239;
307;
311;
314;
930.5;
931;
- acetone -- 402;
403;
563;
- acetonitrile -- 914;
- acetylcholine -- 601;
603;
- acetylglucosamidase -- 167;
- Achromobacter lyticus protease (ALP) -- 196;
- acid conditions (low pH) -- 118;
760;
763;
770;
772;
- acrinol -- 918;
- adenine -- 806;
- adenine triphosphate (ATP) -- 806;
- adenoside deaminase, bovine -- 605;
- adenosine -- 605;
- adipic acid dihydrazide (ADH) -- 454;
- ADSOL -- 702;
- Adsorbable Collagen Sponge (ACS) -- 108;
- affinity chromatography -- 112;
142;
220;
710;
736;
914;
- affinity chromatography, cellufine sulfate -- 144;
- affinity chromatography, concanavalin A -- 168;
168.5;
- affinity chromatography, DNA -- 260;
- affinity chromatography, heparin-like -- 144;
- affinity chromatography, peptide ligands -- 150.5;
- affinity chromatography, Q-Sepharose-FF -- 144;
- agarose -- 723;
725;
- agarose single-stranded DNA -- 260;
- alanine -- 272;
493.5;
707;
713.7;
714;
- Albumin -- 703.5;
- Albumin (Human) -- 117;
133;
136;
143;
147;
149;
150;
151;
152;
170;
186;
187;
204;
206;
210;
211;
212;
212.5;
263;
402;
403;
491;
492;
493;
494;
496;
504;
526;
527;
529;
533;
534;
540;
601;
603;
604;
606;
615;
624;
625;
626;
708;
710;
711;
719;
721;
722;
723;
724;
725;
726;
736;
736.5;
739.5;
747;
748;
749;
761;
767;
771;
780;
781;
790;
794;
795;
796;
798;
800;
804;
- albumin, bovine -- 310;
463;
464;
651;
- albumin, bovine serum -- 467;
900;
- albumin, ovine -- 908;
- alginate, propylene glycol -- 931;
- alkali lysis -- 609;
- alkaline sterilization -- 108;
- allantoic fluid, chicken -- 190;
- allantoin -- 272;
- alpha factor leader peptide -- 169;
- alpha granules -- 802;
- alpha tocopheryl acid succinate (vitamin E succinate) -- 476;
- alpha-amidating enzyme -- 110;
- alpha-tocopherol
- alpha1-chymotrypsin -- 711;
- alpha1-lipoprotein -- 711;
- alpha2-plasmin inhibitor -- 711;
- aluminium hydroxide -- 446.5;
- aluminium hydroxide, hydrated -- 185;
- aluminium phosphate -- 437.5;
- aluminum -- 437;
724;
- aluminum adjuvant -- 432;
485;
- aluminum hydroxide -- 175;
176;
230;
404;
422;
427;
433;
434;
435;
436;
440;
441;
442;
458;
460;
462;
463;
464;
465;
466;
467;
490;
490;
501;
551;
553;
554;
724;
726;
937;
- aluminum oxide -- 700;
- aluminum phosphate -- 423;
425;
426;
430;
435;
437;
441;
442;
445;
449;
451;
466;
510;
513;
- aluminum phosphate -- 513.3;
528;
550;
552;
559;
937;
- aluminum potassium sulfate (alum) -- 103;
177;
178;
184;
424;
431;
443;
447;
454;
549;
555;
556;
916;
- Amberlite -- 402;
403;
- amelogenin -- 931;
- amidolysis assays -- 268;
- amikacin -- 653;
- amino acid mixture -- 562;
- amino acid oxidases -- 907;
- amino acids -- 530;
- aminocaproic acid -- 606;
- aminohexyl-sepharose gel -- 731;
- aminohydrolase -- 608;
609;
- ammonia -- 605;
609;
611;
- ammonia sulfate -- 804;
- ammonium acetate -- 204;
- ammonium carbonate acid -- 219;
- ammonium chloride -- 795;
- ammonium salts -- 550;
- ammonium sulfate -- 420;
424;
430;
431;
443;
447;
454;
455;
459;
508;
513;
- ammonium sulfate -- 513.3;
544;
547;
549;
555;
556;
601;
609;
912;
916;
- amotosalen
- amphotericin B -- 653;
- amyloid P -- 804;
- amylose resins -- 186;
- Anti-Inhibitor Coagulant Complex ref. standard -- 704;
705;
- antibody photoactivation -- 301;
- Anticoagulant Citrate Dextrose Solution (ACD-A; ACD-B) -- 702;
- Anticoagulant Citrate Phosphate Dextrose Adenine Solution (CPDA-1) -- 702;
- Anticoagulant Heparin Solultion -- 702;
- Antigenic Test for Tetanus Toxoid Component -- 543;
- antithrombin III (AT-III) -- 181;
711;
798;
805;
- ANX resin, Pharmacia Biotech -- 760;
- aprotinin -- 736.5;
- aprotinin, bovine -- 737;
- arcitumomab -- 307;
- arginine -- 191;
- arginine -- 191.1;
215;
268;
269;
270;
493.5;
725;
- arginine hydrochloride -- 267;
736;
- argon -- 307;
- AS(04) adjuvant -- 177;
185;
- AS03 -- 483.7;
- AS03 adjuvant -- 485;
- ascorbic acid -- 305;
562;
- asparaginase, L- -- 611;
- asparagine -- 609;
- aspartic acid -- 493.5;
- aspirin -- 767;
934;
- B2036 -- 259;
- B3-desamido insulin detemir -- 196;
- baby hamster kidney proteins -- 145;
- bacillus Calmette-Guerin (BCG) -- 649.5;
- bacterial capsular polysaccharides -- 443;
451;
452;
455;
460;
498;
502.5;
503;
513;
- bacterial capsular polysaccharides -- 513.3;
513.5;
515;
542;
- Bacteriostatic Water for Injection -- 169;
179;
206;
250;
257;
258;
267;
907;
- barium citrate -- 731;
733;
- bentonite -- 767;
- benzene -- 118;
- benzethonium chloride -- 404;
920;
- Benzonase -- 245;
539;
540;
- benzyl alcohol -- 110;
133;
169;
179;
204;
205;
250;
253;
256;
257;
258;
267;
924.5;
- Bergman cycloaromatization -- 118;
- beta-mercaptoethanol -- 220;
- beta-propiolactone (BPL; beta propiolactone) -- 472;
476;
482;
483;
526;
527;
528;
529;
743;
- beta-propiolactone (BPL) -- 483.3;
- beta-propriolactone (BPL) -- 481;
- beta-propriolactone (BPL) -- 483.2;
- beta-tricalcium phosphate -- 237;
- Biomax-10 membrane (Millipore) -- 113;
- biopharmaceutical products -- 621.5;
- Biorex-70 resin -- 250;
- bis-monomethoxy polyethylene glycol -- 205;
- Blue Sepharose -- 138;
- Blue Sepharose 6 Fast Flow (FF) -- 105;
- borax (disodium tetraborate decahydrate) -- 178;
- Bordetella pertussis fimbriae agglutinogen (Agg) -- 430;
437;
- Bordetella pertussis toxoid, recombinant -- 432;
- botulinum toxin type A protoxin -- 601;
- botulinum toxins -- 413;
600;
602;
- bovine adenoside deaminase -- 605;
- bovine alpha-S1 casein milk-specific promoter -- 113;
- bovine aprotinin -- 737;
738;
- bovine collagen -- 108;
651;
659;
808;
922;
923;
- bovine extracellular collagen matrix -- 651;
- bovine IgG -- 145;
- bovine lung surfactants -- 941;
942;
- bovine milk proteins -- 602;
- bovine pituitary extract -- 651;
- bovine prothrombin -- 920;
- bovine serum -- 494;
526;
565;
- bovine serum albumin -- 445;
- bovine serum albumin (BSA) -- 310;
463;
464;
467;
651;
900;
- bovine serum, fetal -- 491;
492;
493;
496;
504;
531;
534;
- bovine thrombin -- 240;
243;
737;
738;
919;
922;
923;
- bovine thromboplastin -- 920;
- Branched PEG -- 205;
- brilliant green (dye) -- 536;
- bromide -- 454;
- brominated phenols -- 166.5;
- butanol, 2- -- 212;
212.5;
- butanol, 2-methyl-2- -- 212;
212.5;
- Butyl Toyopearl HIC -- 138;
- C-peptide -- 192;
- C1-esterase inhibitor -- 711;
- C7F7 monoclonal antibody -- 149;
- cA2, chimeric tumor necrosis factor Mab -- 264;
- calcitonin-glycine fusion protein -- 110;
- calcium -- 240;
243;
502;
725;
- calcium carbonate -- 530;
- calcium chloride -- 126;
138;
140;
145;
146;
147;
148;
149;
150;
150.5;
151;
152;
268;
474;
- calcium chloride -- 483.2;
487;
617;
618;
719;
723;
724;
736;
736.5;
737;
809;
920;
- calcium oxide -- 700;
- calcium phosphate -- 705;
728;
- calcium phosphate hydroxide -- 457;
- calcium phosphate, beta-tri- -- 237;
- calf thymus DNA -- 260;
- calicheamicin -- 118;
- calicheamicin N-acetyl gamma dimethyl hydrazide -- 118;
- cancer, hairy cell leukemia -- 796;
- Capromab -- 312;
- caprylic acid (caprylate) -- 760;
- carbodiimide (EDAC) -- 454;
455;
459;
- carbodiimide condensation -- 456.5;
- carbohydrate gels, cross-linked sulfated -- 708;
- carbon dioxide (CO2 gas; dry ice) -- 210;
567;
601;
651;
- carbon dioxide (CO2) -- 242;
- carboxymethylcellulose sodium salt -- 251;
- carboxypeptidase-B -- 192;
- carcinoembryonic antigen (CEA) -- 304;
- carcinoembryonic antigen (CEA) monoclonal antibody -- 307;
- casamino-acids -- 185;
- casein hydrolysate -- 420;
- castor oil -- 402;
403;
736;
- CD15 monoclonal antibody -- 305;
- CD20 monoclonal antibody -- 117;
306;
- CD25 subunit of IL-2 receptor -- 222;
- CD3 antibodies -- 131;
- CD33 murine IgG1 monoclonal antibody -- 118;
- CD34 monoclonal antibody, murine -- 701;
- cellufine sulfate affinity chromatography -- 144;
- cellulose acetate phthalate (CAP) -- 402;
403;
- cementum -- 931;
- Cenolate -- 308;
- ceramide -- 167;
- ceramide trihexoside -- 161;
- certolizumab -- 266;
- ceruloplasmin -- 713.7;
714;
- cesium chloride (CsCl) -- 175;
261.7;
- cetic acid -- 234;
- cetrimonium bromide -- 498;
500;
502;
- cetyltrimethylammonium bromide (CTAB) -- 474;
481;
487;
- CH-Sepharose 4B, activated -- 240;
- chelate EMD copper chromatography -- 144;
- Chelating Sepharose fast flow (Pharmacia)
- chelation -- 311;
312;
314;
- Chelex-100, Bio-Rad -- 240;
243;
- Chemilog process -- 934;
- chicken proteins -- 474;
487;
529;
- chloroform -- 614;
942;
- cholera toxin B, recombinant -- 415;
- cholesterol -- 942;
- chondroitin sulfate -- 105;
- ChromaPlus process -- 776;
780;
- chromatography, chelate EMD copper -- 144;
- chromatography, tandem anion-exchange -- 760;
- Chromogenic Substrate -- 150;
- chromosulphonic acid -- 742;
- chrondroitin-6-sulfate -- 659;
- chymopapain -- 701;
- Citrate Phosphate Double Dextrose Solution (CP2D) -- 702;
- citric acid -- 110;
133;
136;
167;
170;
220;
227;
231;
257;
265;
310;
415;
474;
487;
532;
702;
771;
795;
- CLB-FIX D4, murine monoclonal antibody -- 732;
- Cohn Fraction II -- 771;
785;
- Cohn Fraction IV -- 705;
- collagen -- 658;
659;
- collagen, bovine -- 108;
109;
922;
- collagen, porcine dermal -- 652;
657;
- collagenases -- 907;
- Complement-Fixation Test -- 932;
- concanavalin A affinity chromatography -- 168;
168.5;
- conjugates (see also radioimmune conjugates; immunotoxins; fusion proteins) -- 417;
513.5;
- copper -- 110;
- copper (CU+2) chelating Sepharose Fast Flow (FF) -- 105;
- CorrTest -- 779;
- corticosteroids -- 221;
222;
- Corynebacterium diphtheriae CRM197 protein -- 444;
451;
457;
501;
513;
- Corynebacterium diphtheriae CRM197 protein -- 513.3;
- Corynebacterium diphtheriae CRM197 protein (CRM197) -- 502.5;
- CpG DNA sequences -- 945;
- cresol, meta- -- 195;
196;
197;
198;
234;
239;
248;
248;
252;
254;
- CRM197 protein -- 451;
457;
501;
513;
- CTAA16.88 monoclonal antibody -- 121;
- CTH -- 161;
- cyanoborohydride -- 457;
- cyanogen bromide -- 456.5;
- cyanogen bromide (CNBr) -- 192;
260;
804;
908;
- cyclopentaperhydrophenanthrene:lactone -- 914;
- cyclopentaperhydrophenanthrene:lactoneÐkeyhole limpet hemocyanin (KLH) conjugate -- 914;
- cyclosporine -- 221;
222;
- cystamine -- 542;
- cysteine -- 307;
493.5;
908;
935;
936;
- cystine -- 423;
493.5;
530;
- CYT-063 monoclonal antibody -- 314;
- cytokeratin tumor antigen -- 121;
- Cytomegalovirus Immune Globulin Paste -- 748;
- cytomegalovirus major immediate early region 2 mRNA -- 946;
- D(RH1) antibodies -- 779;
- DAB389 -- 220;
- Daronrix -- 485;
- DEAE cellulose -- 730;
- DEAE Sepharose -- 118;
138;
713.7;
714;
805;
- DEAE Sepharose -- 105;
- dense bodies -- 802;
- deoxyribonuclease (DNase) -- 614;
624;
907;
- dermatan sulfate -- 105;
188;
- desamido-somatropin -- 248;
- detergent -- 481;
- dextran matrix -- 118;
518;
- dextrose -- 212;
212.5;
218;
402;
403;
423;
702;
733;
806;
- dextrose monohydrate
- DIAION HP 20 -- 181;
- diatomite silica (diatomaceous earth) -- 700;
- dibasic sodium phosphate -- 248;
- dibutyl phthalate -- 621.5;
- diethylenetriaminepentaacetic acid (DTPA) -- 302;
310;
- digoxin (or digitoxin) -- 913;
914;
915;
- digoxin-albumin conjugate -- 913;
- digoxindicarboxymethoxylamine (DDMA) -- 914;
- Diluent for Nutropin Depot -- 251;
- dimethicone -- 621.5;
- dimethylsulfoxide (DMSO) -- 606;
652;
- dipalmitoylphosphatidylcholine (DPPC) -- 941;
942;
943;
- Diphtheria and Tetanus Toxoids Adsorbed Combined Bulk (For Further Manufacturing Use -- 436;
- diphtheria toxin -- 220;
419;
420;
502.5;
503;
- diphtheria toxin-neutralizing antibody fragments -- 916;
- Diphtheria Toxoid -- 419;
420;
421;
422;
423;
424;
425;
426;
427;
428;
429;
430;
431;
432;
433;
434;
435;
436;
437;
437.5;
439;
440;
441;
442;
443;
444;
445;
446;
446.5;
447;
448;
449;
450;
451;
452;
454;
502.5;
503;
555;
556;
557;
558;
559;
- dipotassium hydrogen phosphate -- 268;
- disodium hydrogen phosphate -- 221;
255;
263;
409;
415;
472;
483;
526;
566;
928;
- disodium hydrogen phosphate dihydrate -- 195;
- disodium hydrogen phosphate dodecahydrate -- 927;
- disodium phosphate -- 175;
196;
253;
254;
440;
474;
485;
487;
561;
796;
- disodium phosphate dihydrate -- 166.5;
- disulfide solution -- 268;
- dithiothreitol (DTT) -- 212;
212.5;
219;
743;
765;
- divinyl sulfone (DVS) -- 928;
- DL-alpha-tocopherol (vitamin E) -- 483.7;
- DNA oxidative cleavage -- 118;
- DNA repair enzymes -- 260;
- DNA, human -- 141;
- DNA, mammalian -- 564;
- double-stranded DNA -- 948;
- doxorubicin -- 628;
- Dulbecco's Modified Eagle Medium (DMEM) -- 530;
- Duploject syringe -- 737;
738;
- Durapore membrane -- 454;
- DV50 membrane filter -- 227;
- dye affinity chromatography -- 142;
- Dynabeads -- 701;
- egg proteins -- 483.2;
- egg proteins -- 483.3;
- egg
487;
- elastin -- 658;
- ellagic acid -- 705;
- enamelin -- 931;
- enteric coating (tablets) -- 402;
562;
621.5;
- EpCAM
131.5;
- Erythrina trypsin inhiibitor (ETI)-Sepharose -- 268;
- ethanamine -- 794;
- ethanol -- 208;
402;
403;
419;
458;
491;
492;
496;
514;
515;
542;
552;
609;
620;
704;
705;
712;
716;
723;
728;
729;
731;
743;
747;
748;
752;
754;
758;
760;
761;
765;
766;
767;
768;
770;
771;
772;
774;
775;
777;
779;
780;
781;
782;
785;
787;
788;
791;
796;
800;
805;
917;
929;
- ethanolamine -- 651;
- ethyl ether -- 443;
453;
470;
471;
478;
479;
480;
- ethyl mercury -- 908;
939;
- ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) -- 542;
- ethylene glycol -- 795;
- ethylene oxide -- 241;
- ethylenediaminetetraacetic acid (EDTA) -- 169;
212;
212.5;
214;
218;
220;
305;
494;
564;
617;
931;
- F8.1 murine monoclonal antibody -- 147;
148;
721;
722;
- Factor II -- 805;
- Factor IIa -- 150;
805;
- Factor IX -- 704;
798;
805;
- Factor IX murine monoclonal antibody -- 731;
732;
- Factor IX WHO International Standard -- 730;
- Factor IXa -- 805;
- Factor V -- 798;
799;
- Factor VII -- 704;
728;
730;
731;
733;
734;
798;
799;
805;
- Factor VIIa murine monoclonal antibody -- 145;
- Factor VIII -- 716;
739;
798;
- Factor VIII coagulant antigen (F VIII C:Ag) -- 704;
- Factor VIII monoclonal antibodies -- 147;
148;
149;
151;
152;
721;
722;
723;
- Factor VIII peptide ligands -- 150.5;
- Factor VIII SQ murine monoclonal antibody -- 150;
- Factor X -- 728;
729;
730;
731;
733;
734;
799;
805;
- Factor Xa -- 150;
805;
- Factor XI -- 798;
799;
- Factor XII -- 716;
- Factor XIII -- 716;
798;
799;
- fanolesomab -- 305;
- Fast-Flow Q resin, Pharmacia -- 240;
243;
- fatty acids -- 941;
- fatty-acid esters -- 561;
- FD&C blue No.2 -- 621.5;
- FD&C Yellow 5 -- 402;
403;
- Feiba bulk powder -- 737;
738;
- ferric oxide -- 700;
- fetal bovine serum (FBS) -- 531;
- fetuin -- 434;
- fibrin -- 268;
269;
614;
626;
- Fibrin Sealant Warming Tray -- 739;
- fibrinogen -- 626;
716;
726;
737;
738;
739;
798;
799;
920;
921;
922;
923;
- Fibrinogen (Human) -- 736;
- fibrinogen
- fibrinolysin -- 614;
- Fibrinolysis Inhibitor Solution (Synthetic) -- 736.5;
- fibroblast uptake assay -- 105;
- fibronectin -- 716;
724;
- fibronectin, human -- 736;
- filamentous hemagglutinin (FHA), Bordetella pertussis -- 430;
431;
432;
436;
437;
437.5;
439;
441;
442;
506;
507;
- filgrastim -- 159;
- filters, Pall Utrapore VF DV 50 -- 805;
- Filtrate (Effluent) III -- 765;
- First International Reference Preparation for human menopausal gonadotropins (code 70/45) -- 155;
- flavor, raspberry -- 415;
- fluorenyl-methoxycarbonyl (Fmoc) peptide synthesis -- 933;
- FluroTec-coated stopper -- 136;
- follicle-stimulating hormone (FSH) monoclonal antibodies -- 156;
- follicle-stimulating hormone (FSH), oxidized -- 156;
- formaldehyde -- 174;
178;
404;
413;
415;
419;
420;
421;
422;
423;
424;
425;
426;
427;
429;
430;
431;
432;
433;
434;
435;
436;
439;
440;
441;
442;
443;
444;
445;
446.5;
447;
448;
450;
451;
452;
454;
455;
456.5;
457;
459;
460;
462;
463;
464;
465;
466;
467;
469;
472;
474;
475;
476;
477;
478;
481.5;
- formaldehyde -- 483.7;
- formaldehyde -- 483.8;
485;
487;
488;
489;
490;
502.5;
503;
505;
507;
508;
509;
511;
517;
518;
519;
520;
544;
545;
547;
548;
549;
550;
551;
552;
553;
554;
555;
556;
557;
558;
559;
601;
916;
932;
- Fourth Intl. Standard (WHO 88/804) for Factor VIII -- 150;
- Fraction II -- 767;
770;
- Fraction IV -- 705;
- Fractogel, E. Merck TMAE resin -- 760;
- Fresh Frozen Plasma (FFP) -- 716;
- fructose -- 402;
403;
- fucose -- 133;
- fusion protein, proinsulin-tryptophan synthetase -- 192;
- fusion proteins, recombinant -- 110;
242;
- G4000PW HPLC column (TosoHass) -- 220;
- galactose -- 167;
502;
- galactose, O-acylated -- 502;
- galactoseamine -- 605;
- galactosidase -- 167;
- gamma irradiation -- 237;
- gamma radiation sterilization -- 109;
649.5;
808;
900;
922;
- gamma-globulin I paste -- 767;
- Gamunex C-Process -- 760;
- ganciclovir triphosphate -- 261.7;
- Gb-23-902-531 -- 210;
211;
- gelatin -- 494.5;
566;
- gelatin (bovine source) -- 167;
431;
471;
- gelatin (bovine source) -- 483.4;
489;
491;
492;
493;
496;
504;
529;
533;
534;
562;
564;
567;
624;
626;
808;
920;
922;
- gelatin (porcine source) -- 150;
191;
- gelatin (porcine source) -- 191.1;
494;
564;
565;
621.5;
- gentamicin (gentamycin) -- 115;
126;
179;
189;
191;
270;
275;
402;
403;
480;
653;
- gentamicin sulfate -- 191.1;
- gentamicin sulfate -- 476;
- GL- 3 -- 161;
- glass beads -- 742;
- glass particles (mannitol ) -- 194;
- globulin -- 800;
- glucosamine -- 605;
- glucose -- 105;
167;
502;
530;
629;
761;
767;
- glutamate -- 108;
112;
496;
624;
- glutamate buffer -- 160.8;
- glutamic acid -- 138;
140;
- glutamine -- 530;
- glutaraldehyde -- 430;
436;
900;
924;
- glutathione -- 148;
- gluteraldehyde -- 445;
- Gly-Ser linker, fusion protein -- 242;
- glycerin -- 166;
536;
540;
- glycerol -- 105;
195;
197;
250;
- glycerol
- glycerol -- 606;
629;
806;
- glycine -- 102;
110;
138;
140;
144;
149;
151;
194;
206;
215;
216;
221;
227;
245;
248;
252;
253;
254;
255;
259;
305;
493.5;
721;
722;
725;
726;
736;
752;
754;
756;
758;
760;
761;
765;
767;
772;
774;
775;
777;
778;
779;
780;
788;
794;
918;
920;
- glycine-extended precursor -- 110;
- glycoaminoglycan -- 659;
- glycogen -- 166;
- glycoprotein iB receptor -- 802;
- glycoproteins -- 163;
- glycosidase -- 187;
- glycosylation -- 167;
- glycosylation enzymes -- 167;
615;
- glycyl-tyrosyl-(N,-diethylenetriaminepentaacetic acid)-lysine hydrochloride (GYK-DTPA-HCl) -- 312;
314;
- glycylglycine -- 145;
- granulocyte macrophage-colony stimulating factor (GM-CSF) -- 271;
416;
- guanidine hydrochloride -- 220;
- guinea pig potency test -- 544;
555;
559;
- guinea pig test -- 489;
- GYK-DTPA-HCl -- 312;
314;
- Haemaccel -- 150;
167;
- Haemophilus influenzae Protein D -- 513.5;
- Haemophilus influenzae type b capsular polysaccharide (PRP) -- 439;
440;
443;
445;
451;
452;
453;
455;
457;
458;
460;
- hamster proteins -- 147;
149;
151;
152;
- Hank's medium (use Medium 199) -- 467;
- haptoglobulin -- 711;
- heat treatment (pasteurization) -- 102;
169;
267;
415;
469;
517;
521;
563;
620;
626;
703;
704;
705;
707;
708;
711;
712;
713.7;
714;
722;
723;
724;
725;
726;
728;
729;
730;
731;
733;
734;
736;
736.5;
737;
737;
738;
739.5;
752;
765;
766;
767;
771;
772;
774;
775;
777;
785;
788;
791;
800;
917;
929;
- hemagglutinin (HA), influenza A virus -- 462;
476;
477;
483;
- hemagglutinin antigen -- 443;
459;
471;
472;
474;
475;
478;
479;
480;
- hemagglutinin antigen -- 483.2;
- hemagglutinin antigen -- 483.3;
- hemagglutinin antigen -- 483.4;
- hemagglutinin antigen -- 483.7;
- hemagglutinin antigen -- 483.8;
601;
604;
- hemoglobin -- 702;
741;
806;
- hemoglobin, bovine -- 902;
- hemostatic agents -- 809;
- HEp-2 human epidermoid cells -- 795;
- heparan sulfate -- 188;
- heparin -- 181;
188;
702;
705;
707;
724;
725;
728;
733;
734;
804;
805;
- heparin affinity chromatography -- 102;
- heparin-like affinity chromatography -- 144;
- heparin, porcine -- 102;
162;
- heparinase -- 924.5;
- hepatitis B immunoglobulin -- 713.7;
714;
- Hepatitis B Vaccine (Recombinant) -- 460;
753;
754;
- hepatitis B virus pre-S1 antigen -- 176;
- hepatitis B virus surface antigen (HBsAg) -- 452;
- hepatitis B virus surface antigen, recombinant -- 441;
- heptane -- 730;
- HER-2/neu (c-erbB2) proto-oncogene -- 179;
- hexadecyltrimethylammonium bromide -- 561;
- hexoses -- 133;
- histidine -- 114;
144;
146;
147;
148;
150;
- histidine
- histidine -- 152;
179;
184;
189;
214.5;
215;
226;
245;
261.5;
265.5;
276;
493.5;
719;
721;
722;
723;
724;
725;
731;
732;
736.5;
- histidine hydrochloride monohydrate -- 114;
- histidine tags -- 173;
- HLA-DR bioassay -- 213;
- HPC4, murine monoclonal antibody -- 804;
- human chorionic gonadotropin (hCG) -- 615;
- human papillomavirus (HPV) type 16 L1 virus-like particles (VLPs) -- 184;
185;
- human proinsulin (S-sulfonate) -- 192;
- Human Recombinant Alpha 2 (Alpha A), WHO -- 204;
- Hy-Case SF -- 562;
- hyaluronic acid -- 186;
616;
617;
618;
619;
- hyaluronidase -- 624;
907;
- hydrobic interaction chromatography (HIC) -- 265;
- hydrochloric acid -- 166.5;
248;
- hydrochloric acid (HCl) -- 110;
117;
155;
165;
166;
195;
196;
197;
198;
222;
234;
261.5;
307;
311;
314;
465;
626;
712;
723;
731;
774;
794;
933;
949;
- hydrocortisone -- 476;
- hydrophobic interactioN chromatography (HIC) -- 138;
- hydrophobic-interaction column chromatography -- 102;
- hydroxproline -- 493.5;
- hydroxyapatite -- 457;
796;
931;
- hydroxyapatite chromatography -- 142;
144;
- Hydroxyapatite Ultrogel -- 138;
- hydroxyethyl starch (HES) -- 150;
802;
- hydroxylamine -- 900;
- Hypan SS 201 hydrogel -- 260;
- iduronic acid -- 187;
- ifosfamide -- 934.5;
- imidazole -- 149;
151;
614;
725;
- imidazole exchange column -- 173;
- immobilized enzymes -- 908;
- Immune Globulin (Human) -- 750;
- Immune Globulin (Human) Fraction II Bulk Powder -- 754;
- immune globulin (IgM) -- 748;
- immune globulin A (IgA) -- 711;
748;
778;
- immune globulin G type 2a (IgG2a) -- 303;
- immune globulin G1 (IgG1) -- 267;
- immune globulin G4 (IgG4) -- 770;
- immunoaffinity chromatography --